Breaking News Instant updates and real-time market news.

2020-12-01 07:14:52 NEPT Neptune Wellness $1.74 / -0.035 (-1.97%) 07:14 12/01/20 12/01 07:14 12/01/20 07:14	Neptune Wellness provides update on business transition Neptune Wellness Solutions provided an update on its transition and growth strategy from CFO and Global Operating Officer Toni Rinow. The Company is completing its transition over Q3 Fiscal 2021 and Q4 Fiscal 2021 from revenue derived from hemp and cannabis extraction to revenue from consumer packaged goods and branded products, such as Mood Ring - an end-to-end developed and manufactured cannabinoid-based product portfolio targeting both wellness-focused CBD consumers looking for natural products, and the recreational market with THC concentrate product. Neptune is beginning its first commercial production of hashish - comprised of extracted cannabis trichomes utilizing its own proprietary technologies at the company's purpose-built facility in Sherbrooke, Quebec. The hashish products are focused on the recreational market for high THC products and will be available to a footprint totaling 567 retail stores across Ontario and British Columbia, with the opportunity to scale to additional retailers in additional provinces upon securing supply agreements.
NEPT Neptune Wellness $1.74 / -0.035 (-1.97%) 08/27/20 Alliance Global Partners Neptune Wellness deal shows ability to succeed in traditonal category, says AGP 08/07/20 Fly Intel: Top analyst initiations 08/07/20 Alliance Global Partners Neptune Wellness initiated with a Buy at Alliance Global Partners 01/31/20 Cowen Neptune Wellness initiated with a Market Perform at Cowen

2020-12-01 07:14:52

NEPT

Neptune Wellness

$1.74 / -0.035 (-1.97%)

07:14

12/01/20

12/01

07:14

12/01/20

07:14

Neptune Wellness provides update on business transition

Neptune Wellness Solutions provided an update on its transition and growth strategy from CFO and Global Operating Officer Toni Rinow. The Company is completing its transition over Q3 Fiscal 2021 and Q4 Fiscal 2021 from revenue derived from hemp and cannabis extraction to revenue from consumer packaged goods and branded products, such as Mood Ring - an end-to-end developed and manufactured cannabinoid-based product portfolio targeting both wellness-focused CBD consumers looking for natural products, and the recreational market with THC concentrate product. Neptune is beginning its first commercial production of hashish - comprised of extracted cannabis trichomes utilizing its own proprietary technologies at the company's purpose-built facility in Sherbrooke, Quebec. The hashish products are focused on the recreational market for high THC products and will be available to a footprint totaling 567 retail stores across Ontario and British Columbia, with the opportunity to scale to additional retailers in additional provinces upon securing supply agreements.

NEPT Neptune Wellness

$1.74 / -0.035 (-1.97%)

08/27/20 Alliance Global Partners: Neptune Wellness deal shows ability to succeed in traditonal category, says AGP

08/07/20: Fly Intel: Top analyst initiations

08/07/20 Alliance Global Partners: Neptune Wellness initiated with a Buy at Alliance Global Partners

01/31/20 Cowen: Neptune Wellness initiated with a Market Perform at Cowen

TODAY'S FREE FLY STORIES

Conference/Events	Jefferies software/Internet analyst to hold analyst/industry conference call » 10:25 01/20/21 01/20 10:25 01/20/21 10:25 Software & Internet… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Options	Teladoc call volume above normal and directionally bullish » 10:25 01/20/21 01/20 10:25 01/20/21 10:25 TDOC Teladoc $248.27 / +15.53 (+6.67%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 8 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options TDOC Teladoc $248.27 / +15.53 (+6.67%) 01/14/21 Teladoc falls -3.7% 01/14/21 Teladoc down 2% pre-market as UnitedHealth debuts virtual primary care offering 01/14/21 Teladoc issues inaugural corporate social responsibility report 01/11/21 Teladoc, DexCom announce CGM-powered insights for diabetes patients TDOC Teladoc $248.27 / +15.53 (+6.67%) 01/19/21 JPMorgan Teladoc remains top 2021 healthcare technology pick at JPMorgan 01/15/21 Benchmark SOC Telemed initiated with a Buy at Benchmark 01/12/21 BTIG Teladoc price target raised to $260 from $240 at BTIG 01/12/21 Piper Sandler Teladoc visibility improving, fundamentals attractive, says Piper Sandler TDOC Teladoc $248.27 / +15.53 (+6.67%) 10/28/20 Teladoc sees FY20 EPS $(1.36)-($1.32)., consensus ($1.40) 10/28/20 Teladoc sees Q4 EPS (36c)-(33c), consensus (35c) 10/28/20 Teladoc reports Q3 EPS (43c), consensus (32c) 10/28/20 Notable companies reporting after market close TDOC Teladoc $248.27 / +15.53 (+6.67%) 10/01/20 Insurers reduce coverage for virtual doctors' visits, WSJ reports 09/21/20 Teladoc accuses Amwell of patent infringement, STAT reports TDOC Teladoc $248.27 / +15.53 (+6.67%) 12/16/20 Teladoc slides on report of Amazon building telehealth business 10/28/20 Fly Intel: After-Hours Movers 08/05/20 Fly Intel: Pre-market Movers TDOC Teladoc $248.27 / +15.53 (+6.67%) 12/22/20 Teladoc call volume above normal and directionally bullish 12/22/20 Unusually active option classes on open December 22nd 12/21/20 Unusually active option classes on open December 21st 09/01/20 Teladoc call volume above normal and directionally bullish
Conference/Events	First Majestic to host conference call » 10:25 01/20/21 01/20 10:25 01/20/21 10:25 AG First Majestic $13.08 / +0.42 (+3.32%) Management discusses 4Q… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events Options AG First Majestic $13.08 / +0.42 (+3.32%) 07:23 Today First Majestic plans to invest $168.4M on capital expenditures in 2021 07:22 Today First Majestic budgets $42.1M to be invested at Ermitano in 2021 07:20 Today First Majestic sees 2021 total production 20.6M-22.9M silver equivalent ounces 07:18 Today First Majestic reports 2020 silver production of 11.6M ounces AG First Majestic $13.08 / +0.42 (+3.32%) 01/11/21 National Bank First Majestic price target raised to C$20 from C$18 at National Bank 10/22/20 National Bank First Majestic price target lowered to C$18 from C$20 at National Bank 10/20/20 TD Securities First Majestic upgraded to Buy from Hold at TD Securities 09/11/20 National Bank First Majestic price target raised to C$20 from C$19 at National Bank AG First Majestic $13.08 / +0.42 (+3.32%) 11/05/20 First Majestic reports Q3 adj. EPS 12c, two est. (2c) 03/15/21 33rd Annual Roth Virtual Conference 10:00 Today First Majestic - AG AG First Majestic $13.08 / +0.42 (+3.32%) 01/19/21 First Majestic Silver call volume above normal and directionally bullish 12/21/20 First Majestic Silver call volume above normal and directionally bullish 12/16/20 First Majestic Silver call volume above normal and directionally bullish 12/15/20 First Majestic Silver call volume above normal and directionally bullish
Downgrade	TransEnterix downgraded to Neutral on valuation at Ladenburg » 10:24 01/20/21 01/20 10:24 01/20/21 10:24 TRXC TransEnterix $3.72 / +0.255 (+7.36%) Ladenburg Thalmann… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Options TRXC TransEnterix $3.72 / +0.255 (+7.36%) 01/19/21 TransEnterix receives CE Mark for Intelligent Surgical Unit 12/17/20 TransEnterix's Senhance Surgical System adopted by Southern Surgical Hospital 12/16/20 TransEnterix gets approval for Senhance Surgical System in Russia Federation 10/07/20 TransEnterix's Senhance Surgical System adopted by Japan's Toshima Hospital TRXC TransEnterix $3.72 / +0.255 (+7.36%) 10:20 Today Ladenburg TransEnterix downgraded to Neutral from Buy at Ladenburg TRXC TransEnterix $3.72 / +0.255 (+7.36%) 01/06/21 TransEnterix sees FY20 revenue $3.0M-$3.2M, consensus $3.11M 01/06/21 TransEnterix sees Q4 revenue $1.1M, consensus $1.04M TRXC TransEnterix $3.72 / +0.255 (+7.36%) 12/18/20 Largest borrow rate increases among liquid names
Initiation	ProPhase Labs initiated with a Buy at Dawson James » 10:22 01/20/21 01/20 10:22 01/20/21 10:22 PRPH ProPhase Labs $11.88 / -0.07 (-0.59%) Dawson James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Earnings PRPH ProPhase Labs $11.88 / -0.07 (-0.59%) 12/08/20 ProPhase Labs expands COVID testing capacity with location in Garden City ,NY 11/02/20 ProPhase Labs completes acquisition of CLIA accredited lab 10/23/20 ProPhase Labs to acquire CLIA accredited laboratory for $2.5M 09/30/20 ProPhase to explore CLIA lab acquisition, enters agreement with Predictive Labs PRPH ProPhase Labs $11.88 / -0.07 (-0.59%) 08/11/20 ProPhase Labs reports Q2 EPS 1c vs. (11c) last year

Hot Stocks	Barstool's Portnoy says 'pray for everybody else' if profitability matters » 10:22 01/20/21 01/20 10:22 01/20/21 10:22 PENN Penn National $105.97 / +5.71 (+5.70%) Founder of Barstool… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options PENN Penn National $105.97 / +5.71 (+5.70%) 01/19/21 Penn National announces online sports wagering approval in Michigan 01/13/21 New Jersey reports December gaming revenue up 8.9% to $312.9M 01/13/21 Choice Hotels announces loyalty program agreement with Penn National Gaming 01/06/21 New York seeking proposals for mobile sports wagering operator PENN Penn National $105.97 / +5.71 (+5.70%) 09:56 Today Fly Intel: Top five analyst initiations 05:59 Today Credit Suisse Penn National initiated with an Outperform at Credit Suisse 01/14/21 Fly Intel: Top five analyst downgrades 01/14/21 Truist Penn National price target raised to $120 from $85 at Truist PENN Penn National $105.97 / +5.71 (+5.70%) 10/29/20 Penn National reports Q3 EPS 93c, consensus 53c 10/28/20 Notable companies reporting before tomorrow's open 10/28/20 Notable companies reporting before tomorrow's open 08/06/20 Penn National reports Q2 EPS ($1.69), consensus ($2.11) 25 Sep 12 May PENN Penn National $105.97 / +5.71 (+5.70%) 01/11/21 NBA postones Pelicans-Mavs, Celtics-Bulls games 01/08/21 Las Vegas Sands could shift strategy towards sports betting, Bloomberg says 01/08/21 Las Vegas Sands in talks for online sports betting, Bloomberg reports 01/06/21 Cuomo to add mobile sports betting to policy proposals, NY Daily News says PENN Penn National $105.97 / +5.71 (+5.70%) 01/06/21 DraftKings rises on Gov. Cuomo's endorsement of mobile betting in NY 11/04/20 DraftKings, Penn National rise as three more states legalize sports betting 11/04/20 Fly Intel: Pre-market Movers 10/12/20 Street Fight: Credit Suisse says buy DraftKings as Deutsche stays on sidelines 02/04/21 Penn National - PENN PENN Penn National $105.97 / +5.71 (+5.70%) 01/12/21 Penn National call volume above normal and directionally bullish 12/16/20 Penn National call volume above normal and directionally bullish 12/14/20 Penn National call volume above normal and directionally bullish 12/08/20 Penn National call volume above normal and directionally bullish
Downgrade	TransEnterix downgraded to Neutral from Buy at Ladenburg » 10:20 01/20/21 01/20 10:20 01/20/21 10:20 TRXC TransEnterix $3.75 / +0.285 (+8.23%) Ladenburg downgraded… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Earnings Options TRXC TransEnterix $3.75 / +0.285 (+8.23%) 01/19/21 TransEnterix receives CE Mark for Intelligent Surgical Unit 12/17/20 TransEnterix's Senhance Surgical System adopted by Southern Surgical Hospital 12/16/20 TransEnterix gets approval for Senhance Surgical System in Russia Federation 10/07/20 TransEnterix's Senhance Surgical System adopted by Japan's Toshima Hospital TRXC TransEnterix $3.75 / +0.285 (+8.23%) 01/06/21 TransEnterix sees FY20 revenue $3.0M-$3.2M, consensus $3.11M 01/06/21 TransEnterix sees Q4 revenue $1.1M, consensus $1.04M TRXC TransEnterix $3.75 / +0.285 (+8.23%) 12/18/20 Largest borrow rate increases among liquid names
Conference/Events	Jefferies software/Internet analyst to hold analyst/industry conference call » 10:20 01/20/21 01/20 10:20 01/20/21 10:20 Software & Internet… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Periodicals	Kerrisdale says shorting Plug Power, sees 'absurd' valuation » 10:19 01/20/21 01/20 10:19 01/20/21 10:19 PLUG Plug Power $64.04 / -2.38 (-3.58%) Kerrisdale Capital said… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options PLUG Plug Power $64.04 / -2.38 (-3.58%) 01/19/21 Plug Power selects Rochester to host Innovation Center 01/19/21 Plug Power appoints Ole Hoefelmann as GM, electrolyzer business 01/12/21 Renault, Plug Power sign MOU to launch joint venture in France 01/07/21 Plug Power CEO: Korea is going to be a big market for us PLUG Plug Power $64.04 / -2.38 (-3.58%) 01/14/21 JPMorgan Plug Power initiated with a Neutral at JPMorgan 01/13/21 B. Riley Securities Plug Power price target raised to $79 from $52 at B. Riley Securities 01/13/21 Craig-Hallum Plug Power price target raised to $79 from $60 at Craig-Hallum 01/13/21 H.C. Wainwright Plug Power price target raised to $85 from $60 at H.C. Wainwright PLUG Plug Power $64.04 / -2.38 (-3.58%) 11/09/20 Plug Power reports Q3 EPS (11c), consensus (7c) 08/06/20 Plug Power reaffirms 2020 guidance 08/06/20 Plug Power reaffirms 2024 revenue guidance $1.2B 08/06/20 Plug Power reports Q2 EPS (3c), consensus (10c) 17 Nov 12 Aug PLUG Plug Power $64.04 / -2.38 (-3.58%) 12/18/20 Citron says 'no way' would be shorting Vuzix 11/21/20 Plug Power soared this year, Walmart/Amazon could benefit too, Barron's says 08/21/20 Plug Power will drop back to $7, Citron Research says 07/25/20 Bubble forming in Hydrogen fuel-cell stocks, Barron's says PLUG Plug Power $64.04 / -2.38 (-3.58%) 01/14/21 FuelCell drops as JPMorgan says sell after 'massively' outperforming S&P 500 01/12/21 Plug Power jumps after 'transformational' hydrogen venture pact announced 01/06/21 Fly Intel: After-Hours Movers 11/16/20 Fly Intel: After-Hours Movers 03/01/21 26th Annual Energy Virtual Summit 03/15/21 33rd Annual Roth Virtual Conference 01/26/21 Plug Power - PLUG PLUG Plug Power $64.04 / -2.38 (-3.58%) 01/13/21 Plug Power call buyer realizes 90% same-day gains 12/29/20 Plug Power put buyer realizes 15% same-day gains 12/15/20 Plug Power call volume above normal and directionally bullish 12/10/20 Plug Power call volume above normal and directionally bullish
Technical Analysis	NASDAQ market internals summary » 10:17 01/20/21 01/20 10:17 01/20/21 10:17 $NSD NASDAQ Market Internals $0.00 / + (+0.00%) Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NSD NASDAQ Market Internals $0.00 / + (+0.00%) 01/19/21 NASDAQ market internals summary 01/19/21 NASDAQ market internals summary 01/19/21 NASDAQ market internals summary 01/19/21 NASDAQ market internals summary

Hot Stocks	Linde plc announces long-term agreement with BorsodChem » 10:16 01/20/21 01/20 10:16 01/20/21 10:16 LIN Linde plc $259.21 / + (+0.00%) Linde announced it has… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events LIN Linde plc $259.21 / + (+0.00%) 06:24 Today Linde plc signs long-term agreement with BorsodChem to supply chemical complex 01/13/21 Linde to build, own, operate PEM electrolyzer plant for green hydrogen 01/13/21 ITM Power announces sale of 24MW electrolyser to Linde 12/10/20 Linde, Daimler AG to jointly develop hydrogen refueling technology LIN Linde plc $259.21 / + (+0.00%) 01/07/21 Jefferies Jefferies downgrades Air Products to Hold, says 'window has closed too far' 12/10/20 AlphaValue Linde plc upgraded to Reduce from Sell at AlphaValue 12/07/20 Fly Intel: Top five analyst upgrades 12/07/20 Barclays Barclays upgrades Linde to Overweight with $285 price target LIN Linde plc $259.21 / + (+0.00%) 11/05/20 Linde plc raises FY20 adj. EPS view to $8.05-$8.10 from $7.60-$7.80 11/05/20 Linde plc reports Q3 adj. EPS $2.15, consensus $1.97 07/30/20 Linde plc sees FY20 adj. EPS $7.60-$7.80, consensus $7.45 07/30/20 Linde plc sees Q3 adj. EPS $1.90-$1.95, consensus $1.87 02/05/21 Linde plc - LIN
Conference/Events	Jefferies software/Internet analyst to hold analyst/industry conference call » 10:15 01/20/21 01/20 10:15 01/20/21 10:15 Software & Internet… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Hot Stocks	Novo Nordisk seeks FDA approval for new Ozempic dose » 10:10 01/20/21 01/20 10:10 01/20/21 10:10 NVO Novo Nordisk $72.03 / -0.96 (-1.32%) Novo Nordisk announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options NVO Novo Nordisk $72.03 / -0.96 (-1.32%) 01/05/21 Dicerna announces first Novo Nordisk nominated candidate under agreement 01/04/21 Novo Nordisk extends COVID-19 Patient Assistance Program until June 30, 2021 12/29/20 Novo Nordisk files for EU approval of once-weekly semaglutide to treat T2D 12/18/20 Novo Nordisk files for EU approval of once-weekly semaglutide to manage weight NVO Novo Nordisk $72.03 / -0.96 (-1.32%) 06:55 Today Citi Citi opens 'Positive Catalyst Watch' on Novo Nordisk 06:34 Today Credit Suisse Novo Nordisk downgraded to Neutral from Outperform at Credit Suisse 05:28 Today Credit Suisse Novo Nordisk downgraded to Neutral from Outperform at Credit Suisse 01/15/21 Deutsche Bank Novo Nordisk initiated with a Buy at Deutsche Bank NVO Novo Nordisk $72.03 / -0.96 (-1.32%) 10/30/20 Novo Nordisk reports operating profit up 7% at CER in first nine months of 2020 10/08/20 Novo Nordisk boosts 2020 sales growth outlook to 5%-8% from 3%-6% 10/08/20 Novo Nordisk raises sales, operating profit outlook for 2020 08/06/20 Novo Nordisk backs view of 2020 sales growth of 3-6% at CER NVO Novo Nordisk $72.03 / -0.96 (-1.32%) 09/30/20 Before the Move: Watch Novo Nordisk, Bristol into AASLD abstract publication NVO Novo Nordisk $72.03 / -0.96 (-1.32%) 12/16/20 Unusually active option classes on open December 16th
General news	U.S. NAHB housing market index fell 3 points to 83 in January » 10:10 01/20/21 01/20 10:10 01/20/21 10:10 U.S. NAHB housing market… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
General news	Oil Action: WTI crude » 10:10 01/20/21 01/20 10:10 01/20/21 10:10 Oil Action: WTI crude has… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial

Conference/Events	Jefferies basic materials analyst to hold an analyst/industry conference call » 10:07 01/20/21 01/20 10:07 01/20/21 10:07 DNMR Danimer Scientific $32.99 / +3.22 (+10.82%) Basic Materials Analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Options DNMR Danimer Scientific $32.99 / +3.22 (+10.82%) 12/29/20 Live Oak completes business combination, changes name to Danimer Scientific DNMR Danimer Scientific $32.99 / +3.22 (+10.82%) 01/06/21 Jefferies Danimer Scientific initiated with a Buy at Jefferies DNMR Danimer Scientific $32.99 / +3.22 (+10.82%) 01/07/21 Three new option listings and one option delisting on January 7th
Conference/Events	Jefferies basic materials analyst to hold an analyst/industry conference call » 10:02 01/20/21 01/20 10:02 01/20/21 10:02 Basic Materials Analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
General news	Housing Market Index data reported » 10:02 01/20/21 01/20 10:02 01/20/21 10:02 January Housing Market… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Hot Stocks	Precipio signs HemeScreen deals with two oncology groups » 10:01 01/20/21 01/20 10:01 01/20/21 10:01 PRPO Precipio $2.45 / +0.06 (+2.51%) Precipio has signed… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 8 minutes Get Free Trial ShowHide Related Items >><< Company News PRPO Precipio $2.45 / +0.06 (+2.51%) 12/10/20 Precipio reports pact with 'major' U.S. oncology distributor for HemeScreen 08/20/20 Precipio, ADS Biotec sign global distribution agreement for IV-Cell 08/04/20 Precipio launches COVID-19 antibody test in CLIA laboratory 07/30/20 Precipio announces commercial launch of COVID-19 antibody test
Hot Stocks	GasLog falls -7.1% » 10:00 01/20/21 01/20 10:00 01/20/21 10:00 GLOG GasLog $5.28 / -0.38 (-6.71%) GasLog is down -7.1%, or… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings GLOG GasLog $5.28 / -0.38 (-6.71%) 09/17/20 GasLog appoints Kristin Golth to board of directors 08/05/20 GasLog CEO Andy Orekar to step down, Paul Wogan to succeed GLOG GasLog $5.28 / -0.38 (-6.71%) 09/01/20 DNB Markets GasLog upgraded to Buy from Hold at DNB Markets 06/23/20 Fearnley GasLog downgraded to Hold from Buy at Fearnley 06/02/20 Pareto GasLog downgraded to Sell from Hold at Pareto 03/31/20 Pareto GasLog upgraded to Hold from Sell at Pareto GLOG GasLog $5.28 / -0.38 (-6.71%) 08/05/20 GasLog reports Q2 EPS 3c, consensus 0c

Hot Stocks	Studio City falls -7.5% » 10:00 01/20/21 01/20 10:00 01/20/21 10:00 MSC Studio City $16.00 / +1.16 (+7.82%) Studio City is down… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 8 minutes Get Free Trial ShowHide Related Items >><< Company News Earnings MSC Studio City $16.00 / +1.16 (+7.82%) 01/14/21 Studio City falls -9.8% 01/12/21 Studio City falls -3.8% 01/05/21 Studio City falls -6.1% 01/05/21 Studio City falls -14.6% MSC Studio City $16.00 / +1.16 (+7.82%) 08/20/20 Studio City reports Q2 net loss per ADS ($1.51), consensus ($2.84)
Periodicals	Epizyme could be 'vulnerable to an activist investor,' Insightia says » 10:00 01/20/21 01/20 10:00 01/20/21 10:00 EPZM Epizyme $11.80 / + (+0.00%) Following a failure to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings EPZM Epizyme $11.80 / + (+0.00%) 12/24/20 Epizyme says Boehringer Ingelheim terminated collaboration agreement 11/06/20 Epizyme sees funds sufficient into at least 2023 10/07/20 Epizyme's Tazverik Phase 2 data featured in two Lancet Oncology publications EPZM Epizyme $11.80 / + (+0.00%) 12/21/20 Jefferies Epizyme downgraded to Hold at Jefferies on lower than consensus Tazverik view 12/21/20 Jefferies Epizyme downgraded to Hold from Buy at Jefferies 11/09/20 Barclays Epizyme price target lowered to $18 from $33 at Barclays 10/05/20 Citi Citi highlights Epizyme, Karuna as potential targets after MyoKardia takeover EPZM Epizyme $11.80 / + (+0.00%) 11/06/20 Epizyme reports Q3 EPS (55c), consensus (60c) 08/04/20 Epizyme reports Q2 EPS (58c), consensus (61c)
Hot Stocks	Lithium Americas falls -13.9% » 10:00 01/20/21 01/20 10:00 01/20/21 10:00 LAC Lithium Americas $23.07 / -3.73 (-13.92%) Lithium Americas is down… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options LAC Lithium Americas $23.07 / -3.73 (-13.92%) 09:47 Today Lithium Americas falls -14.9% 08:30 Today Lithium Americas trading resumes 07:50 Today Lithium Americas trading halted, news pending 01/19/21 Lithium Americas rises 30.6% LAC Lithium Americas $23.07 / -3.73 (-13.92%) 01/06/21 Canaccord Lithium Americas price target raised to C$20 from C$11.50 at Canaccord 12/23/20 Stifel Stifel starts Lithium Americas with Buy, sees 'attractive upside' 12/22/20 Stifel Lithium Americas initiated with a Buy at Stifel 10/21/20 Roth Capital Lithium Americas downgraded to Neutral from Buy at Roth Capital LAC Lithium Americas $23.07 / -3.73 (-13.92%) 08/14/20 Lithium Americas reports Q2 EPS (7c) vs. (7c) last year 20 Jan LAC Lithium Americas $23.07 / -3.73 (-13.92%) 01/19/21 Fly Intel: After-Hours Movers 09/23/20 Tesla, lithium names under pressure as Wall Street digests Battery Day LAC Lithium Americas $23.07 / -3.73 (-13.92%) 01/13/21 Lithium Americas call volume above normal and directionally bullish 12/23/20 Unusually active option classes on open December 23rd 12/22/20 Lithium Americas call volume above normal and directionally bullish 12/18/20 Largest borrow rate increases among liquid names
Hot Stocks	Yalla rises 8.4% » 10:00 01/20/21 01/20 10:00 01/20/21 10:00 YALA Yalla $39.00 / +12 (+7.00%) Yalla is up 8.4%, or… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate YALA Yalla $39.00 / +12 (+7.00%) 01/11/21 Yalla rises 17.5% 12/18/20 Yalla rises 14.2% 12/16/20 Yalla rises 8.3% 12/15/20 Yalla falls -8.5% YALA Yalla $39.00 / +12 (+7.00%) 12/10/20 Oppenheimer Yalla initiated with a Perform on valuation at Oppenheimer 12/10/20 Oppenheimer Yalla initiated with a Perform at Oppenheimer 10/26/20 Morgan Stanley Yalla initiated with an Equal Weight at Morgan Stanley 30 Sep
Hot Stocks	Veoneer rises 8.8% » 10:00 01/20/21 01/20 10:00 01/20/21 10:00 VNE Veoneer $38.00 / +12 (+5.00%) Veoneer is up 8.8%, or… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events VNE Veoneer $38.00 / +12 (+5.00%) 09:47 Today Veoneer rises 7.7% 01/07/21 Veoneer sees FY20 total order book value $14B 12/17/20 Nokia appoints Nishant Batra as chief strategy, technology officer 12/17/20 Veoneer CTO Nishant Batra to leave for Nokia, Giuseppe Rosso named acting CTO VNE Veoneer $38.00 / +12 (+5.00%) 07:40 Today Deutsche Bank Veoneer price target raised to $20 from $15 at Deutsche Bank 01/07/21 RBC Capital Veoneer downgraded to Underperform from Sector Perform at RBC Capital 01/07/21 RBC Capital Veoneer downgraded to Underperform from Sector Perform at RBC Capital 12/22/20 Citi Citi 'very skeptical' of Apple car, says Tesla most direct competitor VNE Veoneer $38.00 / +12 (+5.00%) 07/24/20 Veoneer reports Q2 revenue $184M, consensus $213.14M VNE Veoneer $38.00 / +12 (+5.00%) 12/22/20 Apple rises as Wall Street digests report of self-driving car plans 10/26/20 Fly Intel: Pre-market Movers 02/03/21 Veoneer - VNE

Events

Earnings calls, analyst events, roadshows and more

UCBI
Today at 11:00

United Community Banks - UCBI Conference Calls
DHI
Today at 11:00

D.R. Horton, Inc. Firm Sponsored Meetings

1341 Horton Circle, Arlington, TX
Today at 11:00

Basic Materials Industry Meetings
Today at 11:00

Basic Materials Industry Meetings
Today at 11:00

Software & Internet Industry Meetings
Today at 12:00

Software & Internet Industry Meetings
Today at 13:00

Software & Internet Industry Meetings
Today at 14:00

Food/Agribusiness Industry Meetings
Today at 14:00

Energy Transition Industry Meetings
KMI
Today at 16:30

Kinder Morgan - KMI Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	TCRR X TCRR TCR2 Therapeutics Secondary Managers: Goldman Sachs, Jefferies, Piper Sandler & BMO Capital Priced at: $30.50 4.59M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRS X ACRS Aclaris Therapeutics Spot Secondary Managers: Cantor Fitzgerald & William Blair, H.C. Wainwright Priced at: $17.50 5.484M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRX X ACRX AcelRx Spot Secondary Managers: Cantor Fitzgerald Priced at: $1.90 14.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BLRX X BLRX BioLineRx Spot Secondary Managers: H.C. Wainwright Priced at: $2.40 12.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BNGO X BNGO Bionano Genomics Spot Secondary Managers: Oppenheimer, BTIG, Ladenburg, Maxim Priced at: $6.00 33.333M Shares DSS X DSS Document Security Spot Secondary Managers: Aegis Priced at: $3.60 6.67M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FULC X FULC Fulcrum Therapeutics Spot Secondary Managers: SVB Leerink, Piper Sandler & Credit Suisse Priced at: $11.00 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LAC X LAC Lithium Americas Spot Secondary Managers: Canaccord, Deutsche Bank, Evercore ISI, Stifel Priced at: $22.00 15.9M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PERI X PERI Perion Network Spot Secondary Managers: Oppenheimer, Stifel, Roth Capital, LAKE Priced at: $11.50 4.99M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYRS X SYRS Syros Pharmaceuticals Spot Secondary Managers: Cowen & Piper Sandler Priced at: $14.00 5.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	BDGE X BDGE Bridge Bancorp Block Trade Managers: Morgan Stanley $25.50-26.50 700K Shares
Wed	DFH X DFH Dream Finders Homes IPO Managers: BofA, RBC Capital & BTIG, Builder Advisor, Zelman, TCB Capital, Wedbush $12.00-15.00 9.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MYTE X MYTE Mytheresa IPO Managers: Morgan Stanley & JPMorgan, Credit Suisse, UBS, Jefferies, Cowen $24.00-26.00 15.647M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RLX X RLX RLX Technology IPO Managers: Citi, China Renaissance $8.00-10.00 116.5M Shares ATHA X ATHA Athira Pharma Secondary Managers: Goldman Sachs, Jefferies, Stifel & JMP Securities $26.55 4M Shares CDNA X CDNA CareDx Secondary Managers: Goldman Sachs & Jefferies, Raymond James, BTIG, Craig-Hallum, H.C. Wainwright $93.33 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CMRX X CMRX Chimerix Secondary Managers: Jefferies & Cowen, H.C. Wainwright, JonesTrading $8.10 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CTMX X CTMX CytomX Therapeutics Secondary Managers: JPMorgan, Cowen & Piper Sandler $8.48 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CYRX X CYRX Cryoport Secondary Managers: Morgan Stanley, Jefferies, SVB Leerink & UBS $76.12 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DYN X DYN Dyne Therapeutics Secondary Managers: JPMorgan, Jefferies, Piper Sandler & Stifel $28.61 5.5M Shares EDIT X EDIT Editas Medicine Secondary Managers: JPMorgan & Morgan Stanley, Cowen, Credit Suisse $72.11 3.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MRUS X MRUS Merus Secondary Managers: Jefferies & SVB Leerink $24.71 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CYRX X CYRX Cryoport Spot Secondary Managers: Morgan Stanley, Jefferies, SVB Leerink & UBS $ Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	PAX X PAX Patria IPO Managers: JPMorgan, BofA & Credit Suisse, Goldman Sachs, Bradesco BBI, BTG Pactual, ITAU, Keefe Bruyette, Santander, XP $14.00-16.00 26.65M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AZEK X AZEK Azek Secondary Managers: Barclays, BofA, Goldman Sachs & Jefferies $42.25 17.5M Shares CRSR X CRSR Corsair Gaming Secondary Managers: Goldman Sachs, Barclays, Credit Suisse, Macquarie, Baird, Cowen, & Stifel, Wedbush, Academy Securities $37.73 7.5M Shares PASG X PASG Passage Bio Secondary Managers: JPMorgan, Goldman Sachs & Cowen, Wedbush, Chardan $29.05 7M Shares
Fri	No deals

View All Syndicate Announcements »

Neptune Wellness provides update on business transition

TODAY'S FREE FLY STORIES

Get Full Fly Access